Current reports
8-K
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
14 May 24
8-K
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
26 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Entry into a Material Definitive Agreement
15 Nov 23
8-K
Departure of Directors or Certain Officers
31 Oct 23
Registration and prospectus
S-8
Registration of securities for employees
16 Jan 24
S-8
Registration of securities for employees
13 Nov 23
10-12B/A
Registration of securities (amended)
26 Oct 23
10-12B
Registration of securities
10 Oct 23
DRS/A
Draft registration statement (amended)
22 Sep 23
DRS/A
Draft registration statement (amended)
24 Aug 23
DRS/A
Draft registration statement (amended)
1 Aug 23
DRSLTR
Correspondence regarding draft registration statement
1 Aug 23
DRS/A
Draft registration statement (amended)
14 Jul 23
DRSLTR
Correspondence regarding draft registration statement
14 Jul 23
Ownership
SC 13G/A
WESTFIELD CAPITAL MANAGEMENT CO LP
8 May 24
4/A
Caroline Loew
11 Apr 24
SC 13G/A
WESTFIELD CAPITAL MANAGEMENT CO LP
4 Apr 24
4
Caroline Loew
4 Mar 24
4
Maiken Keson-Brookes
4 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
BlackRock Inc.
2 Feb 24
SC 13G
WESTFIELD CAPITAL MANAGEMENT CO LP
10 Jan 24
4
Vicki L Goodman
18 Dec 23